Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Xvivo Perfusion AB (publ) XVIPF

Full chart Compare
Set alert

Price alert · XVIPF

All alert types
21.68 USD 0.00 (+0.00%)

At closeNov 3, 2026, 4:00 PM EST

21.80 Day range 21.80
17.46 52-week range 30.95
YTD
+4.73%
1 year
+27.68%

Financial health

Altman Z-Score

13.30 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

6 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B-3 / 5 overall

  • DCF 1
  • Return on Equity 3
  • Return on Assets 4
  • Debt / Equity 4
  • P/E 1
  • P/B 2

Valuation

P/E 239×
FY 2016: 1288×FY 2017: 367×FY 2018: 266×FY 2019: 843×FY 2020: -143×FY 2021: 1000×FY 2022: 345×FY 2023: 105×FY 2024: 83.1×FY 2025: 239×
FY 2016 5y median 239× FY 2025
P/S 7.4×
FY 2016: 14.7×FY 2017: 15.7×FY 2018: 17.9×FY 2019: 19.2×FY 2020: 34.8×FY 2021: 31.2×FY 2022: 15.2×FY 2023: 16.1×FY 2024: 17.4×FY 2025: 7.4×
FY 2016 5y median 16.1× FY 2025
P/B 2.9×
FY 2016: 6.4×FY 2017: 4.6×FY 2018: 6.2×FY 2019: 7.4×FY 2020: 6.2×FY 2021: 6.3×FY 2022: 4.4×FY 2023: 5.0×FY 2024: 6.6×FY 2025: 2.9×
FY 2016 5y median 5.0× FY 2025
P/FCF -39.6×
FY 2016: -256×FY 2017: -183×FY 2018: -108×FY 2019: -78.4×FY 2020: -81.3×FY 2021: -76.1×FY 2022: -61.2×FY 2023: -98.8×FY 2024: 353×FY 2025: -39.6×
FY 2016 5y median -61.2× FY 2025
EV/EBITDA 38.3×
FY 2016: 123×FY 2017: 95.1×FY 2018: 104×FY 2019: 135×FY 2020: -220×FY 2021: 196×FY 2022: 93.4×FY 2023: 113×FY 2024: 48.2×FY 2025: 38.3×
FY 2016 5y median 93.4× FY 2025
EV/Sales 7.2×
FY 2016: 14.6×FY 2017: 14.4×FY 2018: 16.9×FY 2019: 18.5×FY 2020: 32.8×FY 2021: 29.7×FY 2022: 14.6×FY 2023: 15.3×FY 2024: 17.0×FY 2025: 7.2×
FY 2016 5y median 15.3× FY 2025
FCF Yield -2.5%
FY 2016: -0.4%FY 2017: -0.5%FY 2018: -0.9%FY 2019: -1.3%FY 2020: -1.2%FY 2021: -1.3%FY 2022: -1.6%FY 2023: -1.0%FY 2024: 0.3%FY 2025: -2.5%
FY 2016 5y median -1.3% FY 2025

Profitability

Gross Margin 65.7%
FY 2016: 74.0%FY 2017: 76.4%FY 2018: 72.4%FY 2019: 73.7%FY 2020: 73.9%FY 2021: 72.9%FY 2022: 71.5%FY 2023: 74.5%FY 2024: 75.0%FY 2025: 65.7%
FY 2016 5y median 72.9% FY 2025
Operating Margin 11.5%
FY 2016: 2.0%FY 2017: 4.8%FY 2018: 7.5%FY 2019: 1.8%FY 2020: -25.4%FY 2021: -7.2%FY 2022: 1.5%FY 2023: 0.7%FY 2024: 10.7%FY 2025: 11.5%
FY 2016 5y median 1.5% FY 2025
Net Margin 3.1%
FY 2016: 1.1%FY 2017: 4.2%FY 2018: 6.8%FY 2019: 2.2%FY 2020: -24.3%FY 2021: 3.2%FY 2022: 4.4%FY 2023: 15.4%FY 2024: 20.9%FY 2025: 3.1%
FY 2016 5y median 4.4% FY 2025
ROE 1.2%
FY 2016: 0.5%FY 2017: 1.2%FY 2018: 2.3%FY 2019: 0.9%FY 2020: -4.3%FY 2021: 0.6%FY 2022: 1.3%FY 2023: 4.7%FY 2024: 8.0%FY 2025: 1.2%
FY 2016 5y median 1.3% FY 2025
ROIC 2.7%
FY 2016: 0.4%FY 2017: 1.2%FY 2018: 1.9%FY 2019: 0.7%FY 2020: -3.2%FY 2021: -1.3%FY 2022: 0.3%FY 2023: 0.2%FY 2024: 3.4%FY 2025: 2.7%
FY 2016 5y median 0.3% FY 2025
ROA 1.1%
FY 2016: 0.4%FY 2017: 1.2%FY 2018: 2.2%FY 2019: 0.8%FY 2020: -3.8%FY 2021: 0.5%FY 2022: 1.1%FY 2023: 4.2%FY 2024: 7.2%FY 2025: 1.1%
FY 2016 5y median 1.1% FY 2025

Growth (YoY)

Revenue -1.5%
FY 2016: 14.9%FY 2017: 7.4%FY 2018: 26.6%FY 2019: 17.5%FY 2020: -18.6%FY 2021: 43.7%FY 2022: 60.7%FY 2023: 43.9%FY 2024: 37.6%FY 2025: -1.5%
FY 2016 FY 2025
Operating Income 5.0%
FY 2016: -62.1%FY 2017: 159.9%FY 2018: 97.0%FY 2019: -71.9%FY 2020: -1259.3%FY 2021: 59.5%FY 2022: 134.6%FY 2023: -34.7%FY 2024: 2010.2%FY 2025: 5.0%
FY 2016 FY 2025
EPS (diluted) -85.3%
FY 2016: -70.8%FY 2017: 242.9%FY 2018: 100.0%FY 2019: -62.5%FY 2020: -994.4%FY 2021: 117.4%FY 2022: 121.4%FY 2023: 395.2%FY 2024: 77.2%FY 2025: -85.3%
FY 2016 FY 2025
Free Cash Flow -474.4%
FY 2016: -71.9%FY 2017: -60.1%FY 2018: -143.9%FY 2019: -74.4%FY 2020: -42.0%FY 2021: -37.9%FY 2022: 2.9%FY 2023: 5.3%FY 2024: 141.5%FY 2025: -474.4%
FY 2016 FY 2025

Financial Health

Current Ratio 5.8×
FY 2016: 3.3×FY 2017: 8.6×FY 2018: 6.5×FY 2019: 4.9×FY 2020: 6.4×FY 2021: 5.2×FY 2022: 3.5×FY 2023: 6.1×FY 2024: 4.6×FY 2025: 5.8×
FY 2016 5y median 5.2× FY 2025
Quick Ratio 3.7×
FY 2016: 2.1×FY 2017: 7.6×FY 2018: 5.7×FY 2019: 4.1×FY 2020: 5.6×FY 2021: 4.5×FY 2022: 2.7×FY 2023: 5.1×FY 2024: 3.3×FY 2025: 3.7×
FY 2016 5y median 3.7× FY 2025
Debt / Equity 0.1×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.1×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA -1.1×
FY 2016: -1.4×FY 2017: -8.7×FY 2018: -6.1×FY 2019: -5.0×FY 2020: 12.9×FY 2021: -10.0×FY 2022: -3.6×FY 2023: -6.4×FY 2024: -1.3×FY 2025: -1.1×
FY 2016 5y median -3.6× FY 2025
Interest Coverage 2.1×
FY 2016: 27.1×FY 2017: 65.8×FY 2018: 109×FY 2019: 13.8×FY 2020: -127×FY 2021: -67.0×FY 2022: 10.6×FY 2023: 3.5×FY 2024: -1.4×FY 2025: 2.1×
FY 2016 5y median 2.1× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31